Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm

12 references·15 citing·40 second hop

FromToDepth

this work references cited by second hop

References

2019Diffusion of Innovations 137,320 cited
1977Institutionalized Organizations: Formal Structure as Myth and Ceremony28,271 cited
1999The Audit Society: Rituals of Verification3,583 cited
1995Qualitative Research: Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research2,336 cited
1967TRAINING AND DEVELOPMENT HANDBOOK.925 cited
1993Evaluation of Training905 cited
2010Health systems in transition.600 cited
1989The Swedish Council on Technology Assessment in Health Care365 cited
2001Ten recommendations to improve use of medicines in developing countries319 cited
2003European Healthcare Policies for Controlling Drug Expenditure278 cited
2004Soft law in governance and regulation : an interdisciplinary analysis.241 cited
2006Clinical pharmacology – the first 75 years and a view of the future75 cited

Cited by

2017Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study175 cited
2018Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets159 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2014

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

123 cited

2017High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines104 cited

2012Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications97 cited

2019The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries90 cited

2011Influence of demand-side measures to enhance renin–angiotensin prescribing efficiency in Europe: implications for the future82 cited

2012Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland81 cited

2013Generic Medicines: Solutions for a Sustainable Drug Market?67 cited

2013The reform of the essential medicines system in China: a comprehensive approach to universal coverage62 cited

2015Prescribing efficiency of proton pump inhibitors in China: influence and future directions61 cited

2012Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach60 cited

2014Different initiatives across Europe to enhance losartan utilization post generics: impact and implications60 cited

2017Medicine shortages in Fiji: A qualitative exploration of stakeholders’ views57 cited

2021Evidence-based public policy making for medicines across countries: findings and implications for the future55 cited